A planned trial of a COVID-19 vaccine is restarting in the UK. That drug trial, run by AstraZeneca and Oxford University, was halted last week after a participant in the United Kingdom had an adverse reaction to
A planned trial of a COVID-19 vaccine is restarting in the UK. That drug trial, run by AstraZeneca and Oxford University, was halted last week after a participant in the United Kingdom had an adverse reaction to
